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Epithelial to mesenchymal transition (EMT) is a key step
toward metastasis. MCF7 breast cancer cells condition-
ally expressing the EMT master regulator SNAI1 were
used to identify early expressed microRNAs (miRNAs)
and their targets that may contribute to the EMT process.
Potential targets of miRNAs were identiﬁed by matching
lists of in silico predicted targets and of inversely
expressed mRNAs. MiRNAs were ranked based on the
number of predicted hits, highlighting miR-661, a miRNA
with so far no reported role in EMT. MiR-661 was found
required for efﬁcient invasion of breast cancer cells by
destabilizing two of its predicted mRNA targets, the
cell–cell adhesion protein Nectin-1 and the lipid transfer-
ase StarD10, resulting, in turn, in the downregulation of
epithelial markers. Reexpression of Nectin-1 or StarD10
lacking the 30-untranslated region counteracted SNAI1-
induced invasion. Importantly, analysis of public tran-
scriptomic data from a cohort of 295 well-characterized
breast tumor specimen revealed that expression of
StarD10 is highly associated with markers of luminal
subtypes whereas its loss negatively correlated with the
EMT-related, basal-like subtype. Collectively, our non-
a priori approach revealed a nonpredicted link between
SNAI1-triggered EMT and the down-regulation of
Nectin-1 and StarD10 through the up-regulation of miR-
661, which may contribute to the invasion of breast cancer
cells and poor disease outcome.
Oncogene (2010) 29, 4436–4448; doi:10.1038/onc.2010.181;
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Introduction
Epithelial to mesenchymal transition (EMT) is a
fundamental, transient biological process implicated in
gastrulation or neural crest cell migration during
embryogenesis as well as in wound healing in adults.
In addition, the complex EMT program is reactivated
in carcinoma cells allowing them to dissociate from
the primary tumor to invade the surrounding tissues
and to disseminate to distant organ sites (Kalluri and
Weinberg, 2009). During carcinoma progression, the
hallmarks of EMT are the loss of intercellular junctions
and the acquisition of a ﬁbroblast-like motile and
invasive phenotype, associated with the down-regulation
of epithelial markers and the up-regulation of mesench-
ymal markers (reviewed in Thiery and Sleeman, 2006;
De Wever et al., 2008; Sabbah et al., 2008). Signals
triggering EMT elicit the expression of transcription
regulators, such as SNAI1, that orchestrate key events
of this process and confer invasive behavior to epithelial
cells from various origins (Cano et al., 2000; De Craene
et al., 2005). SNAI1 induces EMT by directly binding
to the promoter of genes encoding proteins, such as
E-cadherin and claudins, and in consequence by repressing
their transcription (reviewed in Peinado et al., 2007).
In addition to the profound alterations of the expression
proﬁles of messenger RNA (mRNA) encoding genes
observed during EMT, recent ﬁndings show that
microRNAs (miRNAs), which are B22nt-long non
coding RNAs that coordinate gene expression at the
post-transcriptional level, also contribute to this process
(reviewed in Cano and Nieto, 2008; Gregory et al.,
2008b). MiRNAs are thought to inhibit virtually all
steps of translation, from initiation to elongation, and
also to cause the destabilization of mRNAs through
imperfect microhomologies with the 30-untranslated
region (UTR) of targeted mRNAs (reviewed in Kim
et al., 2009). Because of the imperfect match between the
sequences of miRNAs and their target mRNAs, public-
data-based in silico predictions yield several hundreds of
potential targets for a given miRNA, making the
identiﬁcation of miRNA targets challenging. Signals
triggering EMT lead to the down-regulation of the
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miR-200 family, which is required for the maintenance
of the epithelial phenotype through the repression of
ZEB1, which has been described to be a negative
regulator of E-cadherin (Korpal et al., 2008; Park et al.,
2008; Gregory et al., 2008a). However, only few up-
regulated miRNAs that contribute to EMT by destabi-
lizing mRNAs have been identiﬁed so far. Among those,
miRNA-9 was proposed to sensitize breast cancer cells
to EMT-inducing signals arising from the tumor
environment by suppressing E-cadherin expression
(Ma et al., 2010). The miRNA-155, which is regulated
in normal mouse mammary gland cells by the TFG-b-
triggered-Smad pathway, contributes to EMT by
targeting RhoA (Kong et al., 2008), whereas miR-29a
contributes to this process through the suppression of
tristetraprolin expression (Gebeshuber et al., 2009). In
addition, EMT is a highly dynamic process, making the
analysis of early modiﬁcations of the repertoire of
miRNAs and of their mRNAs targets challenging.
Here, we performed a systematic, time-resolved
screening to identify miRNAs that are differentially
expressed at early time points of SNAI1-induced EMT
in human breast cancer MCF7 cells previously char-
acterized (Vetter et al., 2009). By a non-a priori
approach that combined large-scale transcriptomic and
in silico data analysis, we were able to identify miR-661
as a novel EMT-associated miRNA and Nectin-1 and
StarD10 as two of its targets. In addition, we showed for
the ﬁrst time that miR-661 as well as its targets
contributed to EMT-associated breast carcinoma cell
invasion. Importantly, in contrast to Nectin-1, the
expression of StarD10 positively associated with mar-
kers of luminal subtypes of breast carcinomas whereas it
negatively correlated with markers of the EMT-related
basal-like phenotype.
Results
Time-resolved transcriptomic analysis of early expressed
miRNAs during EMT in MCF7-SNAI1 cells
To identify miRNAs that are differentially expressed
during EMT, we used MCF7 Tet-Off cells that
conditionally express human SNAI1 under the control
of tetracycline (Vetter et al., 2009). These cells, termed
MCF7-SNAI1, which express SNAI1 as early as 2 h
after induction, allow to study transcriptional events
during EMT in a time-resolved manner, in parallel to
phenotypic modiﬁcations (Vetter et al., 2009). In
agreement with previously reported morphological
modiﬁcations of these cells, epiﬂuorescence microscopy
analysis revealed that typical EMT-linked changes, such
as the reorganization of the actin cytoskeleton and the
down-regulation of Cytokeratin-18 and E-cadherin,
started 12 h after induction (Figure 1a; Vetter et al.,
2009). Concomitant to phenotypic changes, SNAI1
expression readily increased the migration and invasion
capacity of MCF7 cells in Transwell assays when
compared with non-induced cells (Figures 1b and c).
A time series of microarray-based miRNA expression
proﬁling experiments was performed between 4 and 96 h
after SNAI1 induction. Interestingly, down-regulation
of miR-200 family members (miR-200a, miR-200b and
miR-429), which are known to negatively regulate EMT
(Cano and Nieto, 2008), was observed in our cell model,
12 h after induction of SNAI1 (Figure 1d), an observa-
tion that was conﬁrmed by real-time PCR (Supplementary
Figure 1A). To identify miRNAs that may orchestrate
the cascade of events leading to EMT through the
down-regulation of mRNAs, we decided to focus on
early up-regulated miRNAs (at a time point preceding
12 h after SNAI1 induction) whose expression con-
stantly increased after induction of SNAI1. A total of
26 miRNAs corresponding to these criteria were
identiﬁed (Figure 1e). To rank these miRNAs for their
potential impact on mRNAs in SNAI1-induced MCF7
cells, we assumed that miRNAs that are central to the
regulation of epithelial homeostasis and EMT may
target several mRNAs. To narrow down the huge
number (up to 500 hits) of in silico predicted target genes
of the 26 early up-regulated miRNAs to a list of high-
conﬁdence target candidates, we took advantage of the
fact that miRNAs destabilize many of their targets
(Baek et al., 2008; Saumet et al., 2009). Making use of
available time-resolved mRNA proﬁling data obtained
with MCF7-SNAI1 cells (Vetter et al., 2009), we ﬁrst
established a list of mRNAs whose expression was
inversely correlated with that of the up-regulated
miRNAs following induction of SNAI1. Second, we
matched this list with the one of the in silico predicted
targets using miRBase Targets software (http://
microrna.sanger.ac.uk/) of each of the 26 miRNAs.
The number of targets predicted by this approach for an
individual miRNAs ranged from 1 to 28. miR-661 was
predicted to target most of the down-regulated mRNAs
(28 hits, Figure 1e). In support of the biological
relevance of these ﬁndings, only a few up-regulated
messengers were predicted to be targeted by miR-661
(Figure 1e). Early up-regulation of miR-661 was
observed at 4 h and its expression reached the highest
level at 96 h after SNAI1 induction, as conﬁrmed by
qRT–PCR (Figure 1f). This strong predictive partici
pation of miR-661 in the regulation of mRNA transla-
tion during the early phase of EMT prompted us to
further investigate its function in this process.
Inhibition of miR-661 decreases migration and invasion
capacities of breast cancer cells
To assess the contribution of endogenous miR-661 to
EMT-associated events, we inhibited its action by
treating MCF7-SNAI1 cells with miR-661-speciﬁc anti-
sense locked nucleic acid (LNA-661) oligonucleotides
(Lecellier et al., 2005), before the induction of SNAI1.
Cy3-coupled LNAs were used to determine the transfec-
tion efﬁciency that was about 70% of the total cell
population (data not shown). Transfection of LNA-661
did not cause detectable changes of the cell phenotype
under the present experimental conditions (data not
shown), but reduced the migration and invasion
capacities of induced MCF7-SNAI1 cells by 40 and
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35%, respectively, when compared with induced cells
transfected with a scrambled LNA (LNA-sc), used here
as a negative control (Figure 2a). As shown in
Supplementary Figure 1B, these effects were not due
to a decrease in cell proliferation.
Next, we decided to evaluate whether the reduction of
the cell motility mediated by inhibition of miR-661
correlated with gene regulatory events participating in
SNAI1-induced EMT and invasion in MCF7 cells.
Thus, we assessed, by real-time PCR, the expression of
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Figure 2 Expression of miR-661 is required for cell invasion and migration of invasive breast cancer cell lines. (a) Transwell migration
assay (top) and Matrigel invasion assay (bottom) of MCF7-SNAI1-induced cells transfected with the miR-661-speciﬁc antisense LNA
(LNA-661), or with the scrambled LNA (LNA-sc). (b) Real-time PCR analysis of the expression of epithelial markers (Cytokeratin-18
(KRT18), E-cadherin, Claudin-3 and b-catenin) in non-induced or induced MCF7-SNAI1 cells, transfected with miR-661-speciﬁc
antisense LNA (LNA-661), or with LNA-sc. (c) Real-time PCR analysis of miR-661 expression in six cell lines. (d) Transwell migration
assay (top) and Matrigel invasion assay (bottom) of MDA-435 cells transfected with LNA-661 or with LNA-sc. Cell migration and
invasion were analyzed 24 h after seeding in Transwells. Results are represented as the mean±s.e.m. (standard error of mean) of at
least three independent experiments.
Figure 1 Time-resolved transcriptomic analysis of early miRNAs during EMT in inducible MCF7 cells expressing SNAI1.
(a) Immunoﬂuorescence and DAPI staining carried out with Texas Red phalloidin, speciﬁc anti-Cytokeratin-18 (KRT18) and anti-E-
cadherin antibodies in non-induced and 48 h induced MCF7-SNAI1 cells. White bar, 20mm. SNAI1 induction in MCF7-SNAI1 cells
was obtained by removing tetracycline from the culture media (represented in ﬁgures by Tet), conversely the presence of tetracycline
repressed SNAI1 expression (represented in ﬁgures by þTet). (b, c) Evaluation of the MCF7-SNAI1 cell motility after 24 h SNAI1
induction using uncoated Transwells for cell migration (b) or Matrigel-coated Transwells for cell invasion (c). (d) Detection of
expression of miR-200a, miR-200b and miR-429 by miRNA microarrays in MCF7-SNAI1 cells at different time points after SNAI1
induction. (e) Evaluation of the number of mRNAs predicted to be targeted by each miRNA found to be up-regulated at a time point
preceding 12 h after SNAI1 induction. mRNAs that were found previously to be up- or down-regulated after SNAI1 induction (Vetter
et al., 2009) were selected for this analysis. miRBase software (version 13) was used for the target prediction using a minimal score of 17.
NA, prediction not available. (f) Quantitative real-time PCR analyses of miR-661 expression carried out in MCF7-SNAI1 cells at
different time points after SNAI1 induction. Results are represented as the mean±s.e.m. (standard error of mean) of at least three
independent experiments.
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EMT markers and/or of genes with an expected impact on
invasion in induced MCF7-SNAI1 cells treated with
LNA-661 or LNA-sc. We observed a signiﬁcant reduction
of the repression of epithelial markers including Cytoker-
atin-18, Claudin-3, E-cadherin and b-catenin (Figure 2b).
However, in silico predictions had not revealed binding
sites for miR-661 in the 30 UTR of these genes (see the
approach described above) suggesting that their down-
regulation by miR-661 is indirect, implicating so far
nonidentiﬁed direct targets of this miRNA. Conversely,
LNA-661 did not affect the up-regulation of mesenchymal
markers (including ZEB1, SNAI2 and SPARC) induced
by SNAI1 expression (data not shown).
To determine whether the up-regulation of miR-661
was more generally correlated with the invasive behavior
of breast carcinoma cells, we analyzed its expression in
noninvasive (HMEC and MCF10F), weakly invasive
breast cancer cells (T47D and MCF7) or highly invasive
cell lines (MDA-435 and MDA-231). Consistent with its
role in breast cancer cell invasion, miR-661 was highly
expressed in mesenchyme-like, invasive cells compared
with noninvasive human mammary epithelial cells
(Figure 2c), an expression pattern that correlated with
the one of SNAI1 (Supplementary Figure 1C). Further-
more, similar to induced MCF7-SNAI1 cells, LNA-661
transfection decreased the migration and invasion
capacity of highly invasive MDA-435 cells by 37 and
42% respectively, compared with LNA-sc-transfected
control cells (Figure 2d). No effect was observed on cell
phenotype or proliferation (data not shown; Supple-
mentary Figure 1D).
Taken together, our observations suggest that early
up-regulation of miR-661 may have a key role in the
down-regulation of epithelial messengers required for
EMT-associated invasion of carcinoma cells.
Biological validation and characterization of predicted
miR-661 targets
Next, we analyzed the effect of ectopically expressed
miR-661 on the stability of its predicted target
messengers (Figure 1e) in transfected MCF7 cells.
E-cadherin mRNA, which is directly down-regulated
by SNAI1 (Batlle et al., 2000), but which is not a
predicted target of miR-661, was used as a negative
control. As monitored by qRT–PCR, ectopic expression
of miR-661 (Supplementary Figure 1E) did neither
change the level of E-cadherin mRNA nor that of 26 of
its potential targets (Figures 3a and b, representative
mRNAs are shown). In contrast, Nectin-1 and StarD10
decreased at both mRNA and protein levels, as
compared with control cells transfected with the empty
pSuper vector (Figures 3b and c). As shown in
Figure 3d, the expression of Nectin-1 and StarD10
negatively correlated with that of miR-661 (Figure 1f) in
a time course experiment in SNAI1-induced MCF7
cells. The Nectin-1 mRNA decreased between 8 h and
12 h (Figure 3d, top) whereas StarD10 mRNA decreased
between 12 h and 24 h after induction of SNAI1
(Figure 3d, bottom). We performed an immunoﬂuores-
cence analysis of Nectin-1 and StarD10 in non-induced
and induced MCF7-SNAI1 cells. Although Nectin-1
localized, as expected, to cell–cell contacts and co-
distributed with E-cadherin (reviewed in Takai et al.,
2008) in noninduced MCF7-SNAI1 cells (Figure 4a),
StarD10 showed an as yet undescribed localization to the
plasma membrane, and partially co-distributed with
the adherens or tight junctional markers E-cadherin and
ZO-1 (Figures 4b and c). As expected, no immunoﬂuor-
escence signals were detected for Nectin-1 and StarD10 in
induced MCF7-SNAI1 cells (Figures 4d and e).
To corroborate the speciﬁcity of the regulation of
Nectin-1 and StarD10 by miR-661, we treated induced
MCF7-SNAI1 cells with an anti-miR-661 LNA that was
meant to protect bona ﬁde endogenous mRNA targets
of this miRNA from its destabilizing action. In contrast
to other predicted candidates (NQO2, FLII, RNPEL1
and CACNAH1) or to the E-cadherin control, which
were down-regulated in SNAI1-expressing MCF7 cells,
LNA-661 speciﬁcally inhibited the down-regulation of
the Nectin-1 and StarD10 messengers (Figure 5a).
Immunoblot analysis of cell extracts conﬁrmed the
stabilization of Nectin-1 and StarD10 at the protein
level, after LNA-661 transfection (Figure 5b, compare
lane 3 with lane 4). To conﬁrm that the 30 UTRs of
Nectin-1 and StarD10 messengers that contain the miR-
661 binding site are targeted by miR-661, we cloned the
30 UTR of both candidates downstream of renilla
luciferase reporter gene (psiCHECK2-30UTRNectin-1
and psiCHECK2-30UTRStarD10). As expected, Renilla
activity decreased when the two fusion constructs were
transfected into induced MCF7-SNAI1 cells expressing
the miR-661, compared with non-induced MCF7-
SNAI1 cells (data not shown). However, the co-
transfection with LNA-661 but not with LNA-sc
markedly reduced the decrease of Renilla activity in
induced MCF7-SNAI1 cells (Figure 5c). Collectively,
these results show that Nectin-1 and StarD10 mRNAs
are sensitive to miR-661 in epithelial cells undergoing
EMT, suggesting their implication in this process.
Nectin-1 and StarD10 participate in SNAI1-elicited
EMT and invasion
Consistent with the observations made in MCF7-SNAI1
cells, Nectin-1 and StarD10 messengers were found
expressed in the poorly invasive epithelial cells (MCF7
and T47D) that express low levels of miR-661
(Figure 2c), whereas an inverse expression pattern was
observed in the highly invasive ﬁbroblastic-like breast
carcinoma cells (MDA-231 and MDA-435) (Figures 6a
and b, respectively). Because miR-661 expression con-
tributed to the down-regulation of epithelial marker
genes in EMT driven by SNAI1 (Figure 2b), we wanted
to determine whether these regulations were mediated
by its targets Nectin-1 and StarD10 in epithelial breast
cancer cell lines. We performed an RNAi directed
against these two genes in the T47D, MCF7 breast
epithelial cell lines and evaluated by real-time PCR
the expression of epithelial and mesenchymal markers.
The silencing of both genes in the two cell lines
was conﬁrmed by real-time PCR (Supplementary
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Figure 2A). Importantly, consistent with the effects of
miR-661 (Figure 2b), the suppression of its two target
genes signiﬁcantly reduced the expression of epithelial
markers Cytokeratin-18, E-cadherin, b-catenin and
Claudin-3 in both cell lines, whereas the expression of
mesenchymal markers did not change (Figure 6c; data
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Figure 3 miR-661 regulates the expression of Nectin-1 and StarD10. (a) Representative selection of predicted candidate mRNA 30
UTR target binding sites of miR-661. Predictions were performed using miRBase Target version 13 (http://microrna.sanger.ac.uk).
(b, c) Evaluation of the mRNA expression level by real-time PCR (b), and of the protein level by immunoblot analysis (c), 48 h after
forced ectopic expression of pSuper-miR-661 vector or pSuper-empty vector as a negative control in MCF7-SNAI1 cells. (d)
Monitoring by real-time PCR of Nectin-1 (top) and StarD10 (bottom) expression after SNAI1 induction in MCF7-SNAI1 cells.
Results are represented as the mean±s.e.m. (standard error of mean) of at least three independent experiments.
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Figure 4 Subcellular localization of Nectin-1 and StarD10 in MCF7-SNAI1 cells on induction of SNAI1. (a) Immunoﬂuorescence
and phalloidin staining carried out with speciﬁc anti-Nectin-1 and anti-E-cadherin antibodies in non-induced (þTet) MCF7-SNAI1
cells. (b, c) Immunoﬂuorescence and DAPI staining carried out with StarD10-, E-cadherin- (b) or ZO-1-speciﬁc (c) antibodies in
non-induced (þTet) MCF7-SNAI1 cells. (d, e) Immunoﬂuorescence and DAPI staining were performed in non-induced (þTet) and
induced (Tet, 48 h after induction) MCF7-SNAI1 cells using speciﬁc anti-SNAI1 (d, e), anti-Nectin-1 (d) or anti-StarD10
(e) antibodies. Bars, 10mm.
miR-661 expression in SNAI1-induced EMT
G Vetter et al
4442
Oncogene
not shown). This ﬁnding suggested that Nectin-1 and
StarD10 may be part of the same or of converging
regulatory pathways that control the expression of these
epithelial genes.
Next, to investigate the relative contribution of
Nectin-1 and StarD10 to EMT-related invasion,
we ectopically expressed these proteins in induced
MCF7-SNAI1 cells to evaluate whether they may
overcome the invasion-promoting effect of miR-661.
Cells were transfected with Nectin-1 or StarD10 GFP
fusion variants lacking the 30 UTR. The expression of
the corresponding mRNAs was quantiﬁed by real-time
PCR (Supplementary Figure 2B). GFP fusion proteins
showed the same subcellular localization (data not
shown) than the endogenous proteins. Invasion assays
showed that forced expression of GFP-Nectin-1 and
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GFP-StarD10 decreased by 31 and 18%, respectively,
cell invasion in induced MCF7-SNAI1 cells compared
with the GFP control (Figure 6d).
Altogether, these results suggest that the repression of
Nectin-1 and StarD10 through miR-661 contributes to ef-
ﬁcient SNAI1-mediated cell invasion triggered by the EMT
program and that both proteins may function in concert
with other regulators to maintain the epithelial cell state.
StarD10 is a novel molecular marker of the
EMT-associated basal-like breast tumor subtype
Our study results highlight for the ﬁrst time that the loss
of Nectin-1 and StarD10 in breast carcinoma cells is
associated with EMT, which is a key step toward
metastasis. To evaluate the potential of these proteins in
molecular breast tumor subtype classiﬁcation, we
performed a multiclass analysis of variance statistical
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analysis with a previously characterized cohort of 295
breast cancer specimen, classiﬁed into cancer subtypes
based on gene expression proﬁles and disease outcome
(van de Vijver et al., 2002; Fan et al., 2006). StarD10
showed a strong statistical association with breast
cancer subtypes (P¼ 4.910E26), suggesting that
StarD10 expression correlated also with the disease
outcome in these 295 patients (Figure 7). In contrast to
the cell–cell adhesion molecule Nectin-1 for which no
association was determined (data not shown) the
StarD10 was expressed in Luminal A, B (LA and LB)
and Her2þ (HR) tumor subtypes (Figure 7), whereas
its expression was low in the basal-like subtype (BL) that
has been reported to show molecular characteristics of
EMT (Sarrio et al., 2008). To corroborate this ﬁnding,
we determined whether the expression of StarD10
correlated with known molecular markers of the basal-
like and luminal subtypes in the cohort of 295 breast
tumors (van de Vijver et al., 2002; Fan et al., 2006).
Whereas the expression of the luminal molecular
markers FOXA1, GATA3, KRT18 and KRT8 (re-
viewed in Lacroix, 2006) in our data set showed a
positive Pearson’s correlation with that of StarD10,
expression of the basal-like markers KRT5, KRT14 and
FOXC1 (reviewed in Lacroix, 2006) showed a negative
correlation (Table 1). Taken together, these ﬁndings
suggest that the expression of StarD10 allows to
discriminate the basal-like subtype from other major
cancer subtypes. Thus, the loss of StarD10 may be a
novel molecular marker for the EMT-associated basal-
like breast cancer subtype.
Discussion
Malignant cancer cells are known to reactivate a
program leading to EMT, which is also crucial during
physiological processes such as embryonic development
and wound healing in adults. The MCF7-SNAI1-based
proﬁling assay that was previously established (Vetter
et al., 2009) allowed us to associate a speciﬁc miRNA
expression signature with early events and to identify
novel up-regulated miRNAs. We showed that, when
combined with in silico predictions, the time-resolved
inverse expression correlation approach we developed
was very powerful to identify high-conﬁdence target
candidates of the miRNAs that were differentially
expressed during SNAI1-mediated EMT. The results
of our study highlighted miR-661, a miRNA with no
reported function in EMT so far, as important in the
regulatory network leading to cancer cell invasion. In
addition, among the predicted targets of miR-661,
we experimentally conﬁrmed an interaction between
miR-661 and StarD10 or Nectin-1, and showed that
they contribute to EMT-elicited cell invasion through
the repression of epithelial genes. Importantly, our study
revealed for the ﬁrst time that the loss of StardD10
may be a highly relevant marker for the basal-like,
EMT-associated, molecular subtype of breast cancer.
Collectively, these ﬁndings design a new way for the
dissection of regulatory networks contributing to
SNAI1-triggered EMT.
Our ﬁndings emphasize the importance of miRNA-
triggered down-regulation of cell–cell contact proteins
during EMT and cancer cell invasion and are in
concordance with those recently made by Ma et al.
(2010), which underline the role of miR-9 in targeting
E-cadherin during epithelial cell transformation. Indeed,
our study data suggest that miR-661, through destabi-
lization of its two targets Nectin-1 and StarD10, may
contribute to the efﬁcient down-regulation of genes that
contribute to the establishment and maintenance of the
epithelial phenotype. Indeed, miR-661 targeted Nectin-1,
which is known to participate in epithelial cell polarity
and migration through the regulation of cell–cell
junctions and cytoskeleton organization (reviewed in
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Figure 7 Evaluation of StarD10 expression in human breast
tumors. Expression of StarD10 in basal-like (BL), Luminal A, B
(LA and LB), normal-like breast (NBL) and Her2þ (HR) breast
tumor subtypes of 295 human breast tumors characterized in a
previous study (van de Vijver et al., 2002).
Table 1 Pearson’s correlation analysis between StarD10 and tumor
marker expression
StarD10
Basal-like markers
KRT5 0.31702
KRT14 0.14909
FOXC1 0.51169
Luminal markers
FOXA1 0.552127
GATA3 0.501762
KRT18 0.57425
KRT8 0.495991
Pearson’s correlation association between StarD10 and tumor marker
gene expression in the 295 breast tumors characterized by van de Vijver
et al. (2002).
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Sakisaka et al., 2007). As supported by previous data,
the repression of Nectin-1 by miR-661 may contribute
to the disassembly of cell–cell contacts, an early step of
EMT. In addition, as supported by the fact that its
silencing affected the expression of epithelial genes, it is
likely that Nectin-1, in addition to its structural role,
also contributes to gene regulation. Such a dual function
has been described for other cell junction proteins,
including E-cadherin (Onder et al., 2008).
Although endogenous expression of miR-661 was
required for efﬁcient cell invasion, its ectopic over-
expression did not signiﬁcantly modify the migratory or
invasive behavior of MCF7 cells (data not shown),
suggesting that miR-661 may function in synergy with
other factors.
Consistently, silencing of both of its targets in two
independent breast cancer epithelial cell lines (T47D and
MCF7) affected negatively the messenger level of
epithelial genes (Figures 2b and 6c) but was not
sufﬁcient to promote an EMT (data not shown). The
contribution of other miRNAs during the EMT process
is sustained by the observation that miR-200 family
members were down-regulated in SNAI1-expressing
MCF7 cells. Interestingly, in contrast to miR-661,
members of the miR-200 family were down-regulated
at later time points, suggesting that in the cascade
of molecular events leading to EMT, regulation of
miR-661 may precede that of the miR-200 family. The
miR-200 family inhibits EMT and cancer cell migration
by targeting the ZEB1 and ZEB2 oncogenes that
directly repress transcription of the E-cadherin gene, a
key cell–cell adhesion molecule of adherens junctions
(Hurteau et al., 2007; Korpal et al., 2008; Gregory et al.,
2008a). Contrary to the miR-200 family, which indir-
ectly regulates E-cadherin, our study results support a
direct regulation of the Nectin-1 messenger by miR-661.
Furthermore, reexpression of Nectin-1 could overcome
the invasion-promoting effect of miR-661. However,
miR-661-mediated decrease of Nectin-1 was not sufﬁ-
cient to trigger dissociation of cell–cell contacts and an
EMT phenotype (data not shown). This may be
explained in part by the functional redundancy of
Nectin isoforms that are expressed in MCF7 cells
(Supplementary Figure 2C). In line, knockout of
Nectin-1 in a mouse model yielded only a moderate
phenotype (reviewed in Takai et al., 2008), whereas
expression of a dominant-negative variant of Nectin-1
perturbed epithelial cell morphogenesis (Brakeman
et al., 2009). In addition, our ﬁndings support the view
that SNAI1 as well as miR-661 and miR-200 family
members, which are directly or indirectly regulated by
SNAI1, may function in concert to control epithelial cell
plasticity by targeting components of cell–cell junctions.
MiR-661 has been recently reported to be directly up-
regulated by the transcription factor c/EBPa and to
target metastatic tumor antigen 1 in an ectopic forced
expression assay (Reddy et al., 2009). We neither
detected a differential expression of c/EBPa nor of
metastatic tumor antigen 1 in our EMT model (data not
shown). These ﬁndings support the view that several
transcription factors may regulate a speciﬁc miRNA
that may have distinct targets and effects depending on
the cellular state and of its expression level. In line, miR-
29a was recently shown to function either as an
oncogene or as a tumor suppressor depending on the
cellular context (Gebeshuber et al., 2009).
StarD10, the second direct target of miR-661, has
been previously identiﬁed as a breast-carcinoma-asso-
ciated protein (Olayioye et al., 2005). Contrary to
Nectin-1, little information is available on the function
of StarD10 in epithelial cells. StarD10 was proposed to
mediate lipid transfer between intracellular membranes,
a process that may contribute to processes such as
epithelial cell polarity and signaling (Olayioye et al.,
2005). In support of such a role, we observed that
StarD10 mainly localized to the plasma membrane and
colocalized with junction markers. Whether StarD10
contributes directly or indirectly to the assembly and
maintenance of cell–cell contacts requires further
investigation. Interestingly, silencing of StarD10 re-
sulted in the down-regulation of the same epithelial
genes as observed for Nectin-1 silencing, suggesting
coordinate action.
Although overexpression of StarD10 has been shown
to correlate with that of c-erbB and cancer cell
transformation, a recent clinical study has reported
the correlation of the loss of StarD10 with a group of
poor prognosis breast cancers (Murphy et al., 2010).
Our ﬁndings, which show one of the molecular
mechanisms of regulation of the StarD10 expression
during EMT, may reconcile these apparently contro-
versial results. Consistent with previous data (Olayioye
et al., 2004), we found that StarD10 protein is over-
expressed in weakly invasive breast cancer cells, such as
MCF7 or T47D, when compared with normal breast
epithelial cells (Figure 6b). Conversely, StarD10 was
strongly repressed during SNAI1-induced EMT suggest-
ing that transient, miR-661 mediated down-regulation
of StarD10 may occur during cancer progression. In
agreement, expression of StarD10 negatively correlated
with markers of the basal-like subtype that has
mesenchymal molecular features and phenotype (Sarrio
et al., 2008) in a cohort of breast tumors (Table 1). Thus,
one might speculate that the expression of StarD10 may
be correlated with the differentiation status of breast
epithelial cells. In line with this hypothesis, it has been
reported that StarD10 expression increased during
terminal differentiation of breast epithelial cells reaching
its maximum at pregnancy and lactation (Olayioye
et al., 2004). It can, however, not be excluded that
additional factors including transcription factors and
other early up-regulated miRNAs may also contribute
to its robust down-regulation in the basal-like breast
cancer subtype.
Collectively, our study results point to an important
role for miR-661 in cancer cell invasion, a process to
which its targets Nectin-1 and StarD10 may contribute.
In the future, the loss of StardD10 expression may be
used as a novel marker of basal-like tumors that exhibit
mesenchymal features. Our study also paves the way
to further explore the dynamic regulatory networks
underlying SNAI1-mediated EMT.
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Materials and methods
Cell culture
The generation of stable MCF7-SNAI1 cells has been
described before (Vetter et al., 2009). T47D, MDA-231 and
MDA-435 cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine
serum, 2mM L-glutamine, 100U/ml penicillin and 100 mg/ml
streptomycin. Total RNA from human mammary epithelial
and MCF10F cells was a gift from Michele Sabbah’s
laboratory.
Invasion and motility assays
For invasion and motility assays, 5 105 cells were cultured for
24 h in Matrigel-coated or uncoated Boyden chambers (8 mm
pores; BD Biosciences, Erembodegem, Belgium). Cells were
transfected with Lipofectamine 2000 (Invitrogen, Merelbeke,
Belgium) (100 pmol siRNA (Qiagen, Venlo, Netherlands),
100 nM LNA (Sigma-Proligo, Evry, France) or 4mg pSuper
vector (OligoEngine, Seattle, WA, USA)). MCF7-SNAI1 cell
induction was carried out 4 h after transfection. Cell migra-
tion/invasion to the lower side of the ﬁlter was evaluated with
the MTT colorimetric assay (Sigma-Aldrich, Bornem, Bel-
gium).
Cell proliferation analysis
Transfected cells were detached 24 h after transfection and
plated in 12-well plates at a density of 5 104 cells per well.
Cell proliferation was evaluated using the MTT assay during
4 days.
Quantitative RT–PCR detection of mRNAs and miRNAs
Total RNA extraction from cells was performed with the
Trizol reagent (Invitrogen). Reverse transcription was carried
out with random primer (Invitrogen) for mRNA or with
speciﬁc stem-loop oligonucleotides for miRNA detection as
described recently in Saumet et al. (2009). Oligonucleotides
used for miRNA and mRNA detection are detailed in
Supplementary Method 1.
Constructs
The precursor of the miR-661 was ampliﬁed by PCR from
human genomic DNA using gaagatctCCTTCCACAGAG
CAGGG as sense and cccaagcttGGTGCTCTTGGAAAGGC
as antisense oligonucleotide. The resulting amplicon was
cloned into the BglII/HindIII restricted pSuper-retro vector
(OligoEngine). For the ectopic expression of Nectin-1 and
StarD10, we extracted cDNAs from the hORFeome version
5.1 (http://horfdb.dfci.harvard.edu/) and cloned into the pL30-
GFP3X vector using the Gateway technology (Invitrogen).
Immunoﬂuorescence and immunoblotting
For immunoﬂuorescent staining, cells grown to 60–80%
conﬂuency were processed as previously described (Vetter
et al., 2009), before the addition of primary and ﬂuorescently
labeled anti-IgG secondary antibodies. E-cadherin was labeled
with mouse-anti-E-cadherin (BD Biosciences), SNAI1 with
Goat-anti-SNAI1 (Santa Cruz Biotechnology, Heidelberg,
Germany), Cytokeratin-18 with mouse-anti-Cytokeratin-18
(Santa Cruz Biotechnology), Nectin-1 (PVRL1) with rabbit-
anti-Nectin-1 (Santa Cruz Biotechnology) and StarD10 with
goat-anti-StarD10 (Santa Cruz Biotechnology). Actin cytos-
keleton and nuclei were stained with Texas Red phalloidin or
phalloidin-350 (Invitrogen) and DAPI (Sigma-Aldrich). Fluor-
escence imaging was carried out by confocal microscopy
(LSM510; Zeiss, Jena, Germany), and phase contrast imaging
using an inverted microscope (Leica, Howald, Luxembourg).
Immunoblot analyses were carried out using the same primary
antibodies used for immunoﬂuorescence assays. Detection of
GAPDH using the anti-mouse-GAPDH (Sigma-Aldrich) was
performed to estimate the protein amount loaded in each well.
Secondary antibodies against mouse, goat and rabbit coupled
with horseradish peroxidase (Promega, Leiden, Netherlands)
were used for the immunodetection.
DNA microarray and miRNA microarray
DNA microarray assays and data analysis have been described
in Vetter et al. (2009). For miRNA microarray experiments,
total RNA was obtained from three independent MCF7-
SNAI1 cell induction time course assays as described in Vetter
et al. (2009). Total RNA samples were submitted to LC
Sciences company. Experimental conditions and miRNA
microarray data analyzes were carried out by the company
as described on their website (www.lcsciences.com).
Luciferase assay
The 30 UTRs of Nectin-1 and StarD10 mRNAs were fused to
the renilla gene using the XhoI/NotI restriction sites of the
psiCHECK2vector (Promega). A total of 5 104 MCF7-
SNAI1 cells induced for 24 h were co-transfected with 50 ng
of the indicated vector and 100 nM of the indicated LNA
using Lipofectamine 2000 (Invitrogen). Luciferase assays
were performed using the Dual-Luciferase assay (Promega).
Normalization of the Renilla expression was performed using
the luciferase gene present on the psiCHECK2 vector.
siRNA transfection
MCF7 or T47D cells were seeded at a density of 5 104 cells
per well in a six-well plate 1 day before transfection. Cells were
transfected with a speciﬁc siRNA of Nectin-1 and/or StarD10
or a control siRNA using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol. siRNAs sequences
are detailed in Supplementary Method 1.
Expression of Nectin-1 and StarD10 in tumor patients
Expression proﬁling of 295 human breast tumors that were
previously classiﬁed and characterized (van de Vijver et al.,
2002; Fan et al., 2006) was analyzed using an analysis of
variance test to statistically evaluate the association between
the expression of Nectin-1 and StarD10 with tumor subtype
classes.
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